Selected article for: "median progression and survival time"

Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017
  • Document date: 2017_11_7
  • ID: roslkxeq_343
    Snippet: Overall median time to progression (TTP) with first line medical treatment was 99 days (range 32-317 days). Four cats had evidence of disease progression while on chemotherapy and received rescue treatment, with a TTP ranging from 8 to 85 days. In 2 cases, only a clinical response could be assessed; of these, one had renal metastases at diagnosis and the other developed renal metastases while receiving treatment. These two patients initially demo.....
    Document: Overall median time to progression (TTP) with first line medical treatment was 99 days (range 32-317 days). Four cats had evidence of disease progression while on chemotherapy and received rescue treatment, with a TTP ranging from 8 to 85 days. In 2 cases, only a clinical response could be assessed; of these, one had renal metastases at diagnosis and the other developed renal metastases while receiving treatment. These two patients initially demonstrated stable disease but later developed intraocular and retrobulbar metastases, respectively. Of patients with repeat imaging, 1 cat had a partial response, 6 had stable disease and 4 progressive disease. The overall median survival time was 139 days (range 50-497 days). Four cats were still alive at the time of data analysis with a median follow-up of 428 days (range 81-625 days).

    Search related documents:
    Co phrase search for related documents
    • partial response and stable disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58
    • partial response and survival time: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • partial response and treatment receive: 1, 2, 3
    • progressive disease and repeat imaging: 1
    • progressive disease and repeat imaging patient: 1
    • progressive disease and stable disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50
    • progressive disease and survival time: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • progressive disease and treatment receive: 1, 2
    • progressive disease and TTP progression: 1
    • progressive disease and TTP progression median time: 1
    • rescue treatment and treatment receive: 1, 2, 3
    • rescue treatment receive and treatment receive: 1
    • stable disease and survival time: 1, 2, 3, 4, 5, 6, 7
    • stable disease and treatment receive: 1
    • stable disease and TTP progression: 1, 2, 3, 4
    • stable disease and TTP progression median time: 1, 2
    • survival time and treatment receive: 1, 2, 3
    • survival time and TTP progression: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • survival time and TTP progression median time: 1, 2, 3